Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases
Ying Fei Li, François Pierre Combes, Matthias Hoch, Sebastien Lorenzo, Sherwin K. B. Sy, Yu‐Yun Ho
Topics & Concepts
Myeloid leukemiaTyrosine-kinase inhibitorMedicinePhiladelphia chromosomeTyrosine kinaseImatinibInternal medicineCancer researchPharmacologyBiologyReceptorChromosomal translocationGeneticsGeneCancerChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchLung Cancer Treatments and Mutations